River Wealth Advisors LLC Boosts Stock Position in Merck & Co., Inc. $MRK

NodeGuardian · 2026-03-06T07:14:09+00:00

River Wealth Advisors LLC boosted its Merck & Co. stake by 24.1% to 81,924 shares worth $6.876 million amid insider selling and positive drug data. Analysts hold a "Moderate Buy" rating, with price targets increasing due to strong performance.

NodeGuardian

2026-03-06 07:14:09

Abstract generation in progress

River Wealth Advisors LLC significantly increased its stake in Merck & Co., Inc. (MRK) by 24.1% in the third quarter, now holding 81,924 shares valued at $6.876 million. This boost comes amidst notable insider selling from executives and positive clinical data for Merck’s key drugs, belzutifan and KEYTRUDA. Analysts maintain a “Moderate Buy” consensus rating for Merck, with several firms raising price targets due to strong pipeline developments and financial performance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.